Recall of Device Recall ProSpecT Giardia/Cryptosporidium Micorplate Assay.

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Remel, Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class 3
  • Event Number
  • Event Initiated Date
  • Event Date Posted
  • Event Status
  • Event Country
  • Event Terminated Date
  • Event Source
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Giardia Spp. - Product Code MHI
  • Reason
    The conjugate of the prospect giardia/cryptosporidium microplate assay, lot #926230, may have become contaminated during filling. the particulates in the contamination may cause the dropper tips to become plugged. quality control testing indicated that the reagents were still performing as intended, including the conjugates.
  • Action
    A potential contamination was noted in the conjugate in the ProSpecT Giardia/Cryptosporidium Microplate Assay. The particulate in the conjugate may cause the dropper tip to become plugged.


  • Model / Serial
  • Product Classification
  • Device Class
  • Implanted device?
  • Distribution
    US only
  • Product Description
    ProSpecT Giardia/Cryptosporidium Micorplate Assay. Catalog #: 2458496.
  • Manufacturer


  • Manufacturer Address
    Remel, Inc., 12076 Santa Fe Trail Dr, (PO Box 14478, zip 66285-4478), Lenexa KS 66215-3519
  • Source